EUVIMEDEUVIMED entdecken
Crossref

Ibuprofen Reduces 5-Year Overall Survival of Head and Neck Cancer Patients With Immunotherapy – A Retrospective Case-controlled Real-World Data Analysis of 10,000 Patients

Marcel Ebeling, Spyridoula Derka, Josefine Baudrexl, Andreas Sakkas, Mario Scheurer, Frank Wilde, Alexander Schramm, Sebastian Pietzka

Anticancer Research · 2024

DOI: 10.21873/anticanres.16814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Marcel Ebeling und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Plastic Maxillofacial Surgery, Military Hospital Ulm, Academic Hospital of the University of Ulm, Ulm, Germany; Mrclebeling@gm…. Hauptthemen laut MEDLINE: Carcinoma, Ductus Arteriosus, Patent. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinomaDuctus Arteriosus, PatentHumansInfant, NewbornCyclooxygenase InhibitorsData AnalysisIbuprofenImmunotherapyIndomethacinInfant, Low Birth WeightInfant, PrematureProton Pump InhibitorsRetrospective StudiesCase-Control Studies

Stichwörter der Autor:innen

Ibuprofenimmunotherapyreal-world-datasurvival

Substanzen

Cyclooxygenase InhibitorsIbuprofenIndomethacinProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Oral and Plastic Maxillofacial Surgery, Military Hospital Ulm, Academic Hospital of the University of Ulm, Ulm, Germany; Mrclebeling@gmail.com.
  • Department of Oral and Maxillofacial Surgery, Attikon General University Hospital of Athens, Athens, Greece.
  • Department of Internal Medicine and Pulmonology, Military Hospital Ulm, Academic Hospital of the University of Ulm, Ulm, Germany.
  • Department of Oral and Plastic Maxillofacial Surgery, Military Hospital Ulm, Academic Hospital of the University of Ulm, Ulm, Germany.
  • Department of Oral and Plastic Maxillofacial Surgery, University Hospital Ulm, Ulm, Germany.

Zitieren

APA

Ebeling, M., Derka, S., Baudrexl, J., Sakkas, A., Scheurer, M., Wilde, F., Schramm, A., & Pietzka, S. (2024). Ibuprofen Reduces 5-Year Overall Survival of Head and Neck Cancer Patients With Immunotherapy – A Retrospective Case-controlled Real-World Data Analysis of 10,000 Patients. Anticancer Research. https://doi.org/10.21873/anticanres.16814

Vancouver

Ebeling M, Derka S, Baudrexl J, Sakkas A, Scheurer M, Wilde F, et al. Ibuprofen Reduces 5-Year Overall Survival of Head and Neck Cancer Patients With Immunotherapy – A Retrospective Case-controlled Real-World Data Analysis of 10,000 Patients. Anticancer Research. 2024. doi:10.21873/anticanres.16814

BibTeX
@article{Ebeling2024,
  author = {Ebeling, Marcel and Derka, Spyridoula and Baudrexl, Josefine and Sakkas, Andreas and Scheurer, Mario and Wilde, Frank and Schramm, Alexander and Pietzka, Sebastian},
  title = {Ibuprofen Reduces 5-Year Overall Survival of Head and Neck Cancer Patients With Immunotherapy – A Retrospective Case-controlled Real-World Data Analysis of 10,000 Patients},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16814}
}
Kostenlos starten →